Clinical trial
Dynepo Infrequent Dosing Study
NCT00450333 · Shire, Industry · Terminated
Key facts
| NCT number | NCT00450333 |
|---|---|
| Title | Dynepo Infrequent Dosing Study |
| Official title | An Open-Label, Phase IIIb, Multi-Centre, Randomised, Parallel-Group Study to Investigate the Efficacy and Safety of Three Dosing Schedules of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease Who Are Pre-Dialysis or Require Peritoneal Dialysis or Haemodialysis |
| Lead sponsor | Shire, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Kidney Failure |
| Intervention type | Drug |
| Interventions | Dynepo (Epoetin delta), Dynepo |
| Enrollment | 407 |
| Start date | Oct 30, 2006 |
| Primary completion | Jul 31, 2008 |
| Completion | Jul 31, 2008 |
| First posted | Mar 22, 2007 |
| Last update posted | Jun 14, 2021 |
| Countries | Austria, Belgium, France, Germany, Italy, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: